These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19454884)

  • 1. The problem of placebo-controlled trials allowing rescue medication: how to assess efficacy in rhinosinusitis and allergic rhinoconjunctivitis when both groups receive active rescue treatment.
    Vent J; Lehmacher W
    Curr Opin Allergy Clin Immunol; 2009 Jun; 9(3):222-7. PubMed ID: 19454884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal corticosteroids and allergic rhinoconjunctivitis.
    Origlieri C; Bielory L
    Curr Opin Allergy Clin Immunol; 2008 Oct; 8(5):450-6. PubMed ID: 18769200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication.
    Akerlund A; Andersson M; Leflein J; Lildholdt T; Mygind N
    J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of combined symptom and medication scores for rhinoconjunctivitis immunotherapy clinical trials.
    Clark J; Schall R
    Allergy; 2007 Sep; 62(9):1023-8. PubMed ID: 17686105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials.
    Penagos M; Compalati E; Tarantini F; Baena-Cagnani CE; Passalacqua G; Canonica GW
    Allergy; 2008 Oct; 63(10):1280-91. PubMed ID: 18721246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
    Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of azelastine nasal spray for the treatment of allergic rhinitis.
    Lee TA; Pickard AS
    Pharmacotherapy; 2007 Jun; 27(6):852-9. PubMed ID: 17542768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis.
    Bousquet PJ; Combescure C; Klossek JM; Daurès JP; Bousquet J
    J Allergy Clin Immunol; 2009 Jun; 123(6):1349-54. PubMed ID: 19368963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of mometasone furoate nasal spray in the treatment of sinusitis or acute rhinosinusitis].
    Klossek JM
    Rev Laryngol Otol Rhinol (Bord); 2007; 128(3):187-92. PubMed ID: 18323331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review.
    Baiardini I; Braido F; Tarantini F; Porcu A; Bonini S; Bousquet PJ; Zuberbier T; Demoly P; Canonica GW;
    Allergy; 2008 Jun; 63(6):660-9. PubMed ID: 18445183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based study design in ocular allergy trials.
    Katelaris CH; Bielory L
    Curr Opin Allergy Clin Immunol; 2008 Oct; 8(5):484-8. PubMed ID: 18769206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal duration of allergic rhinitis clinical trials.
    Krouse JH; Roland PS; Marple BF; Wall GM; Hannley M; Golla S; Hunsaker D
    Otolaryngol Head Neck Surg; 2005 Oct; 133(4):467-87; discussion 488. PubMed ID: 16213915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce.
    Canonica GW; Baena-Cagnani CE; Bousquet J; Bousquet PJ; Lockey RF; Malling HJ; Passalacqua G; Potter P; Valovirta E
    Allergy; 2007 Mar; 62(3):317-24. PubMed ID: 17298350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome measures of specific immunotherapy.
    Pfaar O; Anders C; Klimek L
    Curr Opin Allergy Clin Immunol; 2009 Jun; 9(3):208-13. PubMed ID: 19365259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper.
    Braido F; Bousquet PJ; Brzoza Z; Canonica GW; Compalati E; Fiocchi A; Fokkens W; Gerth van Wijk R; La Grutta S; Lombardi C; Maurer M; Pinto AM; Ridolo E; Senna GE; Terreehorst I; Todo Bom A; Bousquet J; Zuberbier T; Baiardini I
    Allergy; 2010 Aug; 65(8):959-68. PubMed ID: 20486919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy.
    Didier A; Melac M; Montagut A; Lhéritier-Barrand M; Tabar A; Worm M
    Allergy; 2009 Jan; 64(1):166-71. PubMed ID: 19076546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intranasal steroid therapy in inflammatory nasal-sinus pathology in pediatric age].
    Berlucchi M; Tomenzoli D
    Minerva Pediatr; 2009 Jun; 61(3):323-31. PubMed ID: 19461575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allergic rhinoconjunctivitis and immunotherapy: an update].
    Leimgruber A; Spertini F
    Rev Med Suisse; 2009 Jan; 5(186):88-93. PubMed ID: 19238924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
    Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
    Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy in allergic rhinoconjunctivitis: new horizons.
    Mahr TA
    Allergy Asthma Proc; 2007; 28(4):404-9. PubMed ID: 17883907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.